GENIE: Genomics Evidence Neoplasia Information Exchange
Studies
0
It is a multi-phase, multi-year, international, pancancer registry, built through data sharing, with the goals of powering precision oncology and clinical decision making.
Visit GENIE
Members
| Investigators | Contacts |
|---|---|
|
|
General Information
- Year created
- 2017
- Types of cohorts
-
- Patient/disease cohort
- Countries
-
- Canada
- France
- Netherlands
- Spain
- United Kingdom
- United States of America
- Setting
- International
- Funding
- Funded through several resources including sponsored research, collaborative projects with other non-profit organizations, a non-competitive collaboration with 10 biopharmaceutical companies and NIH NCI supplements.
- Criteria of cohort's to be included
- The database currently contains CLIA-/ISO-certified genomic data obtained during the course of routine practice at multiple international institutions. Cases were included based on diagnosis of cancer and availability of genomic data. Institutions willing to participate are require to provide 500 genomic records to start; 500 each subsequent year of participation.
- Health topic
-
- Cancer
- Genomics
- Socio-environmental context
-
- NA
Participants
Number of participants
- Total
- 126,000
- With harmonized data
- 126,000
Age range of the samples
- Minimum age
- 0
Methodology for harmonization and integration
- Strategy of harmonization
- Ex-post
- Data processing methods
-
- NA
- Type of infrastructure
- Data are centrally located
- Integrative data analysis
-
- Pooled analyses
- Software
-
- NA
- Supplementary information
- https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001337.v1.p1&phv=420776&phd=&pha=&pht=9620&phvf=&phdf=&phaf=&phtf=&dssp=1&consent=&temp=1
Number of cohorts
- Total
- 19
- With harmonized data
- 19
- Will more cohorts be harmonized?
Access
- Availability of metadata
- Under request
- Availability of individual data
- Under request